Cargando…
(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
Despite the achievements of antiretroviral therapy, discovery of new anti-HIV medicines remains an essential task because the existing drugs do not provide a complete cure for the infected patients, exhibit severe adverse effects, and lead to the appearance of resistant strains. To predict the inter...
Autores principales: | Stolbov, Leonid A., Druzhilovskiy, Dmitry S., Filimonov, Dmitry A., Nicklaus, Marc C., Poroikov, Vladimir V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983201/ https://www.ncbi.nlm.nih.gov/pubmed/31881687 http://dx.doi.org/10.3390/molecules25010087 |
Ejemplares similares
-
How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors
por: Pogodin, Pavel V., et al.
Publicado: (2018) -
CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds
por: Lagunin, Alexey A., et al.
Publicado: (2018) -
Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human Body
por: Filimonov, Dmitry A., et al.
Publicado: (2020) -
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1
por: Tarasova, Olga, et al.
Publicado: (2020) -
Prediction of Severity of Drug-Drug Interactions Caused by Enzyme Inhibition and Activation
por: Dmitriev, Alexander, et al.
Publicado: (2019)